FINPROM Findings
2“Directors who participated in the Fundraise are set out in the table below ... Oberon Capital (Sole Bookrunner and Joint Broker) ... Winterflood Retail Access Platform”
Directors participated in the Fundraise (disclosed in a table). Oberon was Sole Bookrunner while Winterflood ran only the retail sleeve — clean split but confirms that in these cases WINS is not running the bookbuild, they are purely the retail distribution utility.
“a discount of approximately 11.6 per cent. to the mid-market closing price of an Ordinary Share on 19 September 2025 ... and a premium of 39 per cent. to the Company's 90 day closing average share price”
Explicit comparison to 90-day average is a BETTER-than-standard disclosure practice. Provides retail investors with richer pricing context than the minimal 'last close' discount number.
RNS Announcements
2£7.05m total gross proceeds from Fundraise
THIS ANNOUNCEMENT. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF THE LAWS OF ENGLAND AND WALES PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (" UK MAR "). UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE WITHIN THE PUBLIC DOMAIN. Renalytix plc (" Renalytix " or the " Company ") £7.05m total gross proceeds from Fundraise Oversubscribed WRAP Offer, combines with Placing and Subscription, and Additional Subscription LONDON …
WRAP Retail Offer for up to £500,000
THIS ANNOUNCEMENT. THE COMMUNICATION OF THIS ANNOUNCEMENT AND ANY OTHER DOCUMENTS OR MATERIALS RELATING TO THE WRAP RETAIL OFFER AS A FINANCIAL PROMOTION IS ONLY BEING MADE TO, AND MAY ONLY BE ACTED UPON BY, THOSE PERSONS IN THE UNITED KINGDOM FALLING WITHIN ARTICLE 43 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED (WHICH INCLUDES AN EXISTING MEMBER OF RENALYTIX Plc). ANY INVESTMENT OR INVESTMENT ACTIVITY TO WHICH THIS ANNOUNCEMENT RELATES IS AVAILABLE ONLY TO SUCH PERSONS AND WILL BE ENGAGED IN ONLY WITH SUCH PERSONS. THIS ANNOUNCEMENT IS FO…
Board of Directors
18| Name | Role | Appointed | Status |
|---|---|---|---|
| James McCullough | CEO | 2018-03-15 | active |
| Julian Baines | Chairman | 2018-03-15 | active |
| Joel R. Jung | Interim CFO | — | active |
| Christopher Harwood Bernard Mills | Non-Executive Director | 2018-03-15 | active |
| Dr Erik Kristian Lium | Non-Executive Director | 2018-11-06 | active |
| Robert Graham Naylor | Non-Executive Director | 2024-12-02 | active |
| Ann Berman | Director | 2021-07-28 | active |
| Catherine Havlik Coste | Director | 2023-06-30 | active |
| Daniel J. Levangie | Director | 2021-08-31 | active |
| Fergus Fleming | director | 2018-03-15 | active |
| Howard Doran | President | — | active |
| Michael J. Donovan | MD | — | active |
| One Advisory Limited | corporate-secretary | 2026-01-01 | active |
| Doctor Chirag Parikh | Director | 2019-10-14 | active |
| Richard Anthony Evans | director | 2018-03-15 | active |
| Salim Gulamabbas Hamir | secretary | 2018-03-15 | active |
| Dr Barbara Therese Murphy | director | 2018-11-06 | active |
| Timothy Scannell | Director | 2022-03-30 | active |